Evidence for the Detection of Subclinical Retinal Involvement in Systemic Lupus Erythematosus and Sjogren Syndrome: A Potential Association with Therapies

被引:24
|
作者
Conigliaro, Paola [1 ]
Triggianese, Paola [1 ]
Draghessi, Gianluca [2 ]
Canofari, Claudia [1 ]
Aloe, Gianluca [2 ]
Chimenti, Maria Sole [1 ]
Valeri, Claudia [2 ]
Nucci, Carlo [2 ]
Perricone, Roberto [1 ]
Cesareo, Massimo [2 ]
机构
[1] Univ Roma Tor Vergata, Dept Med Sistemi, Rheumatol Allergol & Clin Immunol Unit, Viale Oxford 81, IT-00133 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Expt Med & Surg, Ophthalmol Unit, Rome, Italy
关键词
Hydroxychloroquine; Retina; Systemic lupus erythematosus; Sjogren syndrome; Spectral-domain optical coherence tomography; STANDARD AUTOMATED PERIMETRY; OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; OCULAR MANIFESTATIONS; HYDROXYCHLOROQUINE; GLAUCOMA; DISEASE; CLASSIFICATION; AUTOANTIBODIES; CHLOROQUINE;
D O I
10.1159/000488950
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Retinal involvement in systemic lupus erythematosus (SLE) and Sjogren syndrome (SS) may be subclinical and thus underdiagnosed. Objectives: We aimed at evaluating morphological and functional visual abnormalities in a cohort of SLE and SS patients in the absence of an overt clinical visual impairment. We also investigated potential associations between retinal disorders and disease activity, organ involvement, and treatment with steroid and/or hydroxychloroquine. Methods: The study comprised 42 SLE and 36 primary SS patients and 76 healthy controls (HC). Ophthalmological examination, standard automated perimetry, spectral-domain optical coherence tomography, and fundus perimetry were performed. Results: Retinal thickness of the posterior pole was not different between SLE and HC groups, but it was reduced in the SS group compared with both the HC and the SLE group. In SLE and SS patients, mean defect and pattern standard deviation by standard automated perimetry were higher than in HC. Visual field index values were lower in both SLE and SS patients than in HC. SLE patients with nephritis displayed increased mean defect and pattern standard deviation and reduced visual field index values compared to patients without nephritis. In SLE and SS patients, fundus perimetry differential sensitivity was reduced, and mean defect values were higher than in HC. Disturbances in fundus perimetry in the SLE group were more prevalent in steroid-naive patients and in SS patients who received a cumulative hydroxychloroquine dose >1,000 g. Conclusions: Functional eye impairment was demonstrated in SLE patients, possibly associated with kidney involvement. In SLE, corticosteroids might exert a protective role. Morphological alterations and functional impairment were detected in SS patients, which may be linked to hydroxychloroquine toxicity. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:45 / 56
页数:12
相关论文
共 50 条
  • [21] Evidence of subclinical perimyocardial involvement in patients with systemic lupus erythematosus: late gadolinium enhancement study
    Pastor, A.
    Choong, P.
    Smith, Z.
    Butzbach, B.
    Botnar, R.
    D'Cruz, D.
    Nagel, E.
    Puntmann, V.
    EUROPEAN HEART JOURNAL, 2012, 33 : 932 - 932
  • [22] Shrinking lung syndrome in systemic lupus erythematosus and Sjogren's syndrome
    Singh, R
    Huang, WQ
    Menon, Y
    Espinoza, LR
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2002, 8 (06) : 340 - 345
  • [23] Nephrocalcinosis in a patient with Sjogren's syndrome/systemic lupus erythematosus
    Damasceno Zanuto, Amanda Carolina
    Bueno, Tatiara
    Alvares Delfino, Vinicius Daher
    Mocelin, Altair Jacob
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2012, 58 (03): : 279 - 280
  • [24] POLYAUTOIMMUNITY PHENOMENON IN SYSTEMIC LUPUS ERYTHEMATOSUS: SECONDARY SJOGREN SYNDROME
    Santos, Cristiana S.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S26 - S26
  • [25] Myositis in Systemic Sclerosis, Lupus Erythematosus and Sjogren's Syndrome
    Keck, A. D.
    Jaeger, V. K.
    Walker, U. A.
    AKTUELLE RHEUMATOLOGIE, 2017, 42 (04) : 310 - 315
  • [26] Neuroendocrine changes in systemic lupus erythematosus and Sjogren's syndrome
    Fox, RA
    Moore, PM
    Isenberg, DA
    BAILLIERES CLINICAL RHEUMATOLOGY, 1996, 10 (02): : 333 - 347
  • [27] Sjogren's syndrome and systemic lupus erythematosus: links and risks
    Pasoto, Sandra Gofinet
    de Oliveira Martins, Victor Adriano
    Bonfa, Eloisa
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2019, 11 : 33 - 45
  • [28] Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome
    Ampélas, JF
    Wattiaux, MJ
    Van Amerongen, AP
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2001, 27 (06): : 588 - 599
  • [29] Cytokine polymorphisms in systemic lupus erythematosus and Sjogren's syndrome
    Magnusson, V
    Nakken, B
    Bolstad, AI
    Alarcón-Riquelme, ME
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (1-2) : 55 - 61
  • [30] Pulmonary manifestations of systemic lupus erythematosus and Sjogren's syndrome
    Velazquez, Marco Lopez
    Highland, Kristin B.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (05) : 449 - 464